Cargando…

Comprehensive Analysis of N6-methyladenosine Modification Patterns Associated With Multiomic Characteristics of Bladder Cancer

Purpose: To comprehensively analyze N6-methyladenosine modification patterns in bladder tumors and to further systematically explore the inherent relationships between these modification patterns and multiomic tumor characteristics. Materials and Methods: A total of 901 bladder tumor samples, includ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jingchao, Wang, Jianlong, Wu, Meng, Zhang, Wei, Meng, Lingfeng, Wang, Jiawen, Lv, Zhengtong, Xia, Haoran, Zhang, Yaoguang, Wang, Jianye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733309/ https://www.ncbi.nlm.nih.gov/pubmed/35004726 http://dx.doi.org/10.3389/fmed.2021.757432

Ejemplares similares

Ferroptosis Mediation Patterns Reveal Novel Tool to Implicate Immunotherapy and Multi-Omics Characteristics in Bladder Cancer
por: Liu, Jingchao, et al.
Publicado: (2022)

Predictive role of ferroptosis-related long non-coding RNAs in bladder cancer and their association with immune microenvironment and immunotherapy response
por: Liu, Jingchao, et al.
Publicado: (2022)

Ferroptosis-Related Long Noncoding RNAs Have Excellent Predictive Ability for Multiomic Characteristics of Bladder Cancer
por: Liu, Jingchao, et al.
Publicado: (2022)

Construction and External Validation of a Ferroptosis-Related Gene Signature of Predictive Value for the Overall Survival in Bladder Cancer
por: Liu, Jingchao, et al.
Publicado: (2021)

An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer
por: Ma, Tianming, et al.
Publicado: (2021)

Identification of a Hypoxia-Related Gene Signature for Predicting Systemic Metastasis in Prostate Cancer
por: Xia, Haoran, et al.
Publicado: (2021)

N6-Methyladenosine-Related Long Non-coding RNA Signature Associated With Prognosis and Immunotherapeutic Efficacy of Clear-Cell Renal Cell Carcinoma
por: Ma, Tianming, et al.
Publicado: (2021)

Biochemical recurrence related metabolic novel signature associates with immunity and ADT treatment responses in prostate cancer
por: Wang, Xuan, et al.
Publicado: (2022)

A simplified frailty index and nomogram to predict the postoperative complications and survival in older patients with upper urinary tract urothelial carcinoma
por: Liu, Jianyong, et al.
Publicado: (2023)

Variable frequency stimulation of sacral neuromodulation in black-zone overactive bladder patients: a case report
por: Meng, Lingfeng, et al.
Publicado: (2020)

Nomograms to predict individual prognosis of patients with primary signet ring cell carcinoma of the urinary bladder
por: Ma, Tianming, et al.
Publicado: (2021)

Variable- versus constant-frequency sacral neuromodulation in black-zone overactive bladder patients: a study protocol for a multicenter, prospective, randomized, blind, self-controlled trial
por: Meng, Lingfeng, et al.
Publicado: (2021)

Comprehensive of N1-Methyladenosine Modifications Patterns and Immunological Characteristics in Ovarian Cancer
por: Liu, Jinhui, et al.
Publicado: (2021)

Young age increases the risk of lymph node positivity but improves prognosis in patients with bladder cancer treated via cystectomy: a population-based study
por: Ma, Tianming, et al.
Publicado: (2021)

Systematic oxidative stress indices predicts prognosis in patients with urothelial carcinoma of the upper urinary tract after radical nephroureterectomy
por: Liu, Jianyong, et al.
Publicado: (2023)

m6A Methylation Patterns and Tumor Microenvironment Infiltration Characterization in Clear-Cell Renal Cell Carcinoma
por: Ma, Tianming, et al.
Publicado: (2022)

Comprehensive multiomics analysis of cuproptosis-related gene characteristics in hepatocellular carcinoma
por: Fu, Jie, et al.
Publicado: (2022)

RNA N1-methyladenosine regulator-mediated methylation modification patterns and heterogeneous signatures in glioma
por: Mao, Meng, et al.
Publicado: (2022)

Intermediate-term results of a prospective, multicenter study on remote programming sacral neuromodulation for refractory overactive bladder
por: Zhang, Yaoguang, et al.
Publicado: (2021)

Comprehensive Analysis and Functional Characteristics of Differential Expression of N6-Methyladenosine Methylation Modification in the Whole Transcriptome of Rheumatoid Arthritis
por: Wan, Lei, et al.
Publicado: (2022)

N(6)-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancer
por: Jin, Huan, et al.
Publicado: (2019)

Comprehensive analysis of lncRNAs N(6)-methyladenosine modification in colorectal cancer
por: Zuo, Luo, et al.
Publicado: (2021)

Effect of myeloid ecotropic viral integration site (MEIS) family genes on tumor microenvironment remodeling and its potential therapeutic effect
por: Meng, Lingfeng, et al.
Publicado: (2021)

Current Advances in N6-Methyladenosine Methylation Modification During Bladder Cancer
por: Liu, Qiang
Publicado: (2022)

Pitaya Genome and Multiomics Database (PGMD): A Comprehensive and Integrative Resource of Selenicereus undatus
por: Chen, Canbin, et al.
Publicado: (2022)

Identifying a Ferroptosis-Related Gene Signature for Predicting Biochemical Recurrence of Prostate Cancer
por: Lv, Zhengtong, et al.
Publicado: (2021)

The Role of N(6)-Methyladenosine Modification in Microvascular Dysfunction
por: Zhang, Ye-Ran, et al.
Publicado: (2022)

Multimodal Single‐Cell Analyses Outline the Immune Microenvironment and Therapeutic Effectors of Interstitial Cystitis/Bladder Pain Syndrome
por: Su, Fei, et al.
Publicado: (2022)

Caspase 4 Overexpression as a Prognostic Marker in Clear Cell Renal Cell Carcinoma: A Study Based on the Cancer Genome Atlas Data Mining
por: Meng, Lingfeng, et al.
Publicado: (2021)

Sacral neuromodulation for overactive bladder using the InterStim and BetterStim systems
por: Meng, Lingfeng, et al.
Publicado: (2022)

N6‐methyladenosine RNA modification regulates cotton drought response in a Ca(2+) and ABA‐dependent manner
por: Li, Baoqi, et al.
Publicado: (2023)

N(6)-Methyladenosine mRNA Modification: From Modification Site Selectivity to Neurological Functions
por: Zhang, Zeyu, et al.
Publicado: (2023)

Function of N6-Methyladenosine Modification in Tumors
por: Zhang, Nan, et al.
Publicado: (2021)

DNA methylation-based classification and identification of bladder cancer prognosis-associated subgroups
por: Tian, Zijian, et al.
Publicado: (2020)

Immunogenic Cell Death Associated Molecular Patterns and the Dual Role of IL17RA in Interstitial Cystitis/Bladder Pain Syndrome
por: Zhang, Wei, et al.
Publicado: (2023)

RNA N6-methyladenosine: a promising molecular target in metabolic diseases
por: Li, Yan, et al.
Publicado: (2020)

Regulatory Role of N6-Methyladenosine (m6A) Modification in Osteoarthritis
por: Zhai, Ganggang, et al.
Publicado: (2022)

N(6)-methyladenosine modification—a key player in viral infection
por: Zhang, Xiaoyue, et al.
Publicado: (2023)

The implications of N6-methyladenosine (m6A) modification in esophageal carcinoma
por: He, Cheng, et al.
Publicado: (2023)

Young age increases the risk of lymph-node metastasis in patients with muscle-invasive bladder urothelial carcinoma
por: Tian, Zijian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4ukmtbcs12k5040a9ud0oa936c